Cite
MLA Citation
Ajai Chari et al.. “Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open‐label Phase II study.” British journal of haematology, vol. 192, 2021, pp. 869–878. http://access.bl.uk/ark:/81055/vdc_100122327380.0x00005c